Does Ozempic Cause Weight Loss by Impacting the Brain or the Gut?
A study from The Netherlands examines the impacts of GLP-1 agonists on the central nervous system using fMRI.
Is Ozempic the Gateway Drug for CBT?
Two recent studies show nearly twice the weight loss for patients who undergo group CBT in addition to taking liraglutide, a GLP-1 agonist.
Using Lifestyle Medicine to Treat Illness by Changing Behavior
Lifestyle medicine is a six-sided approach to improving lifestyles as a treatment for chronic disease.
BrainWeighve Eating Addiction Telehealth App Expands UCLA Trial
Telehealth provider, eHealth International, expands their UCLA trial of weight loss app, BrainWeighve.
GLP-1 Drugs Used to Reduce Cancer, Fight Dementia
GLP-1 agonists such as Ozempic and Wegovy are being tested for their ability to impact cancer rates and slow dementia.
Continuation, the Third C of Addiction
How is substance dependence defined? And is long-term, continuous recovery from food addiction possible?